Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary
Authors:
- Birgitte GeorgBGBirgitte Georg
- Christer NilssonCNChrister Nilsson
- Jens D. MikkelsenJMJens D. Mikkelsen
- Birgitte S. WulffBWBirgitte S. Wulff
- Jan FahrenkrugJFJan Fahrenkrug
- 1 February 1995
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 55 (3) , 237-251
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Adenohypophyseal Vasoactive Intestinal Peptide and Neuropeptide Y Responses to Hypothyroidism Are Abolished after Anterolateral Deafferentation of the HypothalamusNeuroendocrinology, 1994
- The Eukaryotic Prohormone-Processing EndoproteasesCellular Physiology and Biochemistry, 1993
- Differential Use of 3’Poly(A) Addition Sites in Vasoactive Intestinal Peptide Messenger Ribonucleic Acid of the Rat Anterior Pituitary GlandJournal of Neuroendocrinology, 1991
- Vasoactive Intestinal Peptide in the Hypothalamus and PituitaryNeuroendocrinology, 1991
- Characterization and Regional Distribution of Peptides Derived from the Vasoactive Intestinal Peptide Precursor in the Normal Human BrainJournal of Neurochemistry, 1989
- Co-existence and co-secretion of the structurally related peptides VIP and PHIScandinavian Journal of Clinical and Laboratory Investigation, 1987
- Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and ratFEBS Letters, 1985
- Immunochemical study on PHI/PHM with use of synthetic peptidesPeptides, 1984
- Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27Nature, 1983
- VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretionNature, 1980